[FATE] QoQ Quarter Result on 31-Mar-2018 [#Q1]

Stock
[FATE] Fate Therapeutics, Inc.
Announcement Date
10-May-2018
Financial Year
2018
Quarter
31-Mar-2018 [#Q1]
Profit Trend
QoQ- -13.11%
YoY- -39.59%
Quarter Report
FATE's Result
FATE's Financial Summary
View:
Show?
Quarter Result
31/12/18 30/09/18 30/06/18 31/03/18 31/12/17 30/09/17 30/06/17 CAGR
Revenue 1,661 1,026 1,027 1,026 1,027 1,026 1,026 37.75%
PBT -16,027 -16,782 -19,654 -14,135 -12,497 -10,684 -9,645 40.16%
Tax 817 339 376 331 -131 378 137 227.78%
NP -16,027 -16,782 -19,654 -14,135 -12,497 -10,684 -9,645 40.16%
Tax Rate - - - - - - - -
Total Cost 17,688 17,808 20,681 15,161 13,524 11,710 10,671 39.93%
Ratio Analysis
31/12/18 30/09/18 30/06/18 31/03/18 31/12/17 30/09/17 30/06/17 CAGR
NP Margin -964.90 -1,635.67 -1,913.73 -1,377.68 -1,216.85 -1,041.33 -940.06 1.74%
Per Share
31/12/18 30/09/18 30/06/18 31/03/18 31/12/17 30/09/17 30/06/17 CAGR
EPS -0.25 -0.31 -0.37 -0.27 -0.29 -0.26 -0.23 5.70%
EPS Diluted -0.25 -0.31 -0.37 -0.27 -0.29 -0.26 -0.23 5.70%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.